Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 2
2017 15
2018 10
2019 11
2020 9
2021 10
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove.
Tsakok T, Saklatvala J, Rispens T, Loeff FC, de Vries A, Allen MH, Barbosa IA, Baudry D, Dasandi T, Duckworth M, Meynell F, Russell A, Chapman A, McBride S, McKenna K, Perera G, Ramsay H, Ramesh R, Sands K, Shipman A; Biomarkers of Systemic Treatment Outcomes in Psoriasis (BSTOP) Study Group; Burden AD, Griffiths CE, Reynolds NJ, Warren RB, Mahil S, Barker J, Dand N, Smith C, Simpson MA. Tsakok T, et al. JCI Insight. 2023 Feb 22;8(4):e156643. doi: 10.1172/jci.insight.156643. JCI Insight. 2023. PMID: 36810251 Free PMC article.
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics.
Al-Janabi A, Eyre S, Foulkes AC, Khan AR, Dand N, Burova E, DeSilva B, Makrygeorgou A, Davies E, Smith CH, Griffiths CEM, Morris AP, Warren RB; BSTOP Study Group and the BADBIR Study Group. Al-Janabi A, et al. J Invest Dermatol. 2023 Aug;143(8):1470-1478.e1. doi: 10.1016/j.jid.2023.01.021. Epub 2023 Feb 15. J Invest Dermatol. 2023. PMID: 36804406 Free article.
Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling.
Soomro M, Stadler M, Dand N, Bluett J, Jadon D, Jalali-Najafabadi F, Duckworth M, Ho P, Marzo-Ortega H, Helliwell PS, Ryan AW, Kane D, Korendowych E, Simpson MA, Packham J, McManus R, Gabay C, Lamacchia C, Nissen MJ, Brown MA, Verstappen SMM, Van Staa T, Barker JN, Smith CH; BADBIR Study Group; BSTOP study group; FitzGerald O, McHugh N, Warren RB, Bowes J, Barton A. Soomro M, et al. Arthritis Rheumatol. 2022 Sep;74(9):1535-1543. doi: 10.1002/art.42154. Epub 2022 Aug 4. Arthritis Rheumatol. 2022. PMID: 35507331 Free PMC article.
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models.
Jalali-Najafabadi F, Stadler M, Dand N, Jadon D, Soomro M, Ho P, Marzo-Ortega H, Helliwell P, Korendowych E, Simpson MA, Packham J, Smith CH, Barker JN, McHugh N, Warren RB, Barton A, Bowes J; BADBIR Study Group; BSTOP Study Group. Jalali-Najafabadi F, et al. Sci Rep. 2021 Dec 2;11(1):23335. doi: 10.1038/s41598-021-00854-x. Sci Rep. 2021. PMID: 34857774 Free PMC article.
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
Andres-Ejarque R, Ale HB, Grys K, Tosi I, Solanky S, Ainali C, Catak Z, Sreeneebus H, Saklatvala J, Dand N, de Rinaldis E, Chapman A, Nestle FO, Barnes MR, Warren RB, Reynolds NJ, Griffiths CEM, Barker JN, Smith CH, Di Meglio P; PSORT Consortium. Andres-Ejarque R, et al. Nat Commun. 2021 Aug 6;12(1):4741. doi: 10.1038/s41467-021-25066-9. Nat Commun. 2021. PMID: 34362923 Free PMC article.
Alcohol misuse is associated with poor response to systemic therapies for psoriasis: findings from a prospective multicentre cohort study.
Iskandar IYK, Lunt M, Thorneloe RJ, Cordingley L, Griffiths CEM, Ashcroft DM; on behalf the British Association of Dermatologists Biologics and Immunomodulators Register and Psoriasis Stratification to Optimise Relevant Therapy Study Groups. Iskandar IYK, et al. Br J Dermatol. 2021 Nov;185(5):952-960. doi: 10.1111/bjd.20577. Epub 2021 Aug 13. Br J Dermatol. 2021. PMID: 34128222
Defining trajectories of response in patients with psoriasis treated with biologic therapies.
Geifman N, Azadbakht N, Zeng J, Wilkinson T, Dand N, Buchan I, Stocken D, Di Meglio P, Warren RB, Barker JN, Reynolds NJ, Barnes MR, Smith CH, Griffiths CEM, Peek N; BADBIR Study Group, on behalf of the PSORT Consortium. Geifman N, et al. Br J Dermatol. 2021 Oct;185(4):825-835. doi: 10.1111/bjd.20140. Epub 2021 Jun 4. Br J Dermatol. 2021. PMID: 33829489
Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy Showcase.
Yiu ZZN, Barker JNWN, Barnes MR, Di Meglio P, Emsley R, Reynolds NJ, Smith CH, Warren RB, Griffiths CEM; PSORT Consortium. Yiu ZZN, et al. J Invest Dermatol. 2021 Aug;141(8):1872-1878. doi: 10.1016/j.jid.2021.02.746. Epub 2021 Mar 24. J Invest Dermatol. 2021. PMID: 33771529 Free article.
52 results